The new assay constitutes a rapid and reliable analytical tool combining simplicity equivalent to that of latex tests with analytical information approaching that of ELISA.
was seen. The variance (CV) was 8-12% within run, is, however, also present in various larger fibrin degradation products occurring in pathological human plasma (5). Most D-dimer-speciflc antibodies also bind to the D-dimer structure embedded in such larger fibrin degradation products. Thus, the analyte measured is a heterogeneous mixture of molecular fragments and complexes between the fragments, sharing the same structural antigenic unit. The development of specific assays for fibrin-derived degradation products made direct analyses in plasma samples possible. The D-dimer assay is widely used in the diagnosis of deep vein thrombosis (6) (7) (8) , pulmonary embolism (9) (10) (11) Here we present a filtration-type immunoassay equipped with a direct color system that combines quantitative properties with rapidity and simple interpretation of results.
MaterIals and Methods Materials
The membrane is positioned over an absorbent pad and is covered by a plastic layer with a hole exposing the membrane (Figure 1 The resulting curve (Figure 3) showed an apparently biphasic linear relationship between NycoCard D-dimer reflectance and ELISA results: a first linear relationship in the D-dimer range 0.6-5.5 mg/L, and a different linear relationship at concentrations <0. 6 mgfL. This appears to be caused by the greater reactivity of the NycoCard D-dimer assay than of the ELISA method for the D-dimer-conflgured molecular species occurring in normal plasma. 
ns ns
Flbrinogen fragment D, obtained by plasmlnolysis of plasma with addition of streptoldnase; lntrallpld; bllirubln; hemoglobin; and hepailn were added to normal plasma samples and to plasma samples with pathological concentrations of D-dlmer. Rh-factor interference was tested In 11 serum samples with natural amounts of Rh-factor and added commercial D-dlmer preparation. 
Reproducibility.
In experiments designed to study the intra-and interassay variance of NycoCard D-dimer, six plasma samples enriched with standard D-dimer in the range 0.5-8 mgfL were analyzed six times daily over a period of 5 days. The results were read by reflectometry to minimize human observer bias. The results (Table 2) show a decreasing within-run variance (12-8% CV) with increasing concentrations of D-dimer. The CV between runs was in the range 10-18%.
Variation of results among analysts was examined by Citrated plasma from a healthy indMdual was enriched with D-dimer standard material to the six approximate concentrations shown. Each sample was tested in six replicates daily over 5 days. The mean value of each day was used to calculate the reproducibility between days, whereas the series obtained the first day was used to calculate the variation between runs. 
Discussion
The standardization of D-dimer assays is hampered by the heterogeneity of the antigen (5) and the variation in specificity of the antibodies used by various suppliers of commercial products. A common feature of such antibodies is that they react well with purified D-dimer, but to a lesser extent with larger fragments where the E-domain is complexed with the D-dimer structural unit (3,4, 19,26,27) .
Upon 
